ASIF has developed a business plan covering the next few years which involves embarking on a number of projects, many with partners.  


Skip Pain

Skip Pain is a study of the efficacy of a biologic drug.  At the start of the study ASIF gave a presentation on the life of someone with AS, the relationship with clinicians and the patient’s perspective on biologics.  During the study ASIF will review the questionnaires and study material for patients and provide input to a newsletter for investigators.

This is a project carried out in partnership with Novartis.